CAREER: Reaction Development and Advancing Spectroscopic Analysis for Selective Labeling and Radiolabeling of Small Molecules

职业:反应开发和推进小分子选择性标记和放射性标记的光谱分析

基本信息

  • 批准号:
    2237610
  • 负责人:
  • 金额:
    $ 65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Continuing Grant
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

With support of the Chemical Synthesis Program in the Division of Chemistry, Joseph Clark of Marquette University is studying processes for the preparation of small molecules incorporating tritium (and/or deuterium) atomic labels and complementary analytical techniques to characterize and probe these materials. Tritium is widely used as a radioactive tracer element in biological and chemical research and molecules labeled with this rare isotope of hydrogen are useful during the development of pharmaceuticals, agrochemicals, and other kinds of important substances. The findings of the funded research are anticipated to permit the incorporation of tritium (/deuterium) into small molecules with a high level of precision, such that the quantity and location of the hydrogen isotope of choice can be finely controlled. The broader impacts of the funded project extend to the benefits accrued to society as Dr. Clark and his research team members engage in a variety of educational and outreach activities. Foremost among these efforts is a holistic undergraduate career development and training program that combines undergraduate summer research experiences with a collaborative pharmaceutical industry and academic workshop jointly facilitated by the University of Puerto Rico Cayey and Marquette University. The program is designed to provide students with critical training to prepare them for successful careers in science, technology, engineering, and mathematics (STEM) and it places an emphasis on attracting participation from individuals belonging to groups traditionally underrepresented in science.Tritium is an ideal tracer nuclide because of its sufficiently long half-life (12.3 years) and the ability to prepare tritiated compounds with high specific activity for a variety of applications in chemical and biological research. For example, tritium-labeled small molecules are often used in radioligand binding assays and also for absorption, distribution, metabolism, and excretion (ADME) studies of drug candidates. Despite the many important roles for tritium-containing molecules, there are a limited number of effective synthetic methods for the selective incorporation of precise quantities of tritium into organic compounds. Furthermore, spectroscopic techniques to characterize and quantify tritiated small molecules, especially enantioisotopomers that are chiral by virtue of isotopic substitution, are either underdeveloped or do not currently exist. To address the first challenge, a suite of copper-catalyzed transfer tritiation and hydrotritiation reactions are being investigated that permit the regio- and stereo-controlled incorporation of tritium-atom labels into various types of alkene and alkyne substrates (including: allenes, 1,3-dienes, and enynes). The development of enantioselective variants of these transformations is also being pursued to allow for access to enantioisotopomers that are chiral by virtue of tritium substitution and/or by virtue of deuterium and tritium substitution. To support reaction development, and in regard to the second challenge identified above, molecular rotational resonance (MRR) spectroscopy is being established as a general analytical technique to quantify enantiomeric excess of enantioisotopomeric materials and to determine their absolute configurations. It is anticipated that the findings from this research will expand access to selectively tritiated small molecules as useful tools for understanding how metabolites and/or pharmaceutical agents are processed in biological systems.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
在化学系化学合成项目的支持下,马奎特大学的约瑟夫·克拉克正在研究制备小分子的过程,这些小分子包含氚(和/或氘)原子标记和补充分析技术,以表征和探测这些材料。氚被广泛用作生物和化学研究中的放射性示踪元素,用这种稀有的氢同位素标记的分子在药物,农用化学品和其他种类的重要物质的开发过程中是有用的。预计资助研究的结果将允许以高精度将氚(/氘)掺入小分子中,从而可以精细地控制所选氢同位素的数量和位置。资助项目的更广泛的影响延伸到社会的好处,因为克拉克博士和他的研究团队成员从事各种教育和推广活动。这些努力中最重要的是一个整体的本科生职业发展和培训计划,该计划将本科生暑期研究经验与波多黎各卡伊大学和马奎特大学共同促进的制药业和学术研讨会相结合。该计划旨在为学生提供关键的培训,为他们在科学,技术,工程,和数学(STEM),它强调吸引属于传统上在科学中代表性不足的群体的个人的参与。氚因其半衰期足够长而成为理想的示踪核素(12.3年),并有能力为化学和生物研究中的各种应用制备具有高比活度的氚化化合物。例如,氚标记的小分子通常用于放射性配体结合测定,也用于候选药物的吸收、分布、代谢和排泄(ADME)研究。尽管含氚分子具有许多重要作用,但将精确量的氚选择性掺入有机化合物的有效合成方法数量有限。此外,用于表征和量化氚化小分子(特别是由于同位素取代而具有手性的对映同位素异构体)的光谱技术要么不发达,要么目前不存在。为了解决第一个挑战,一套铜催化的转移氚化和氢化反应正在研究中,允许区域和立体控制的氚原子标签纳入各种类型的烯烃和炔烃底物(包括:联烯,1,3-二烯,和烯炔)。这些转化的对映选择性变体的开发也在进行中,以允许获得凭借氚取代和/或凭借氘和氚取代而手性的对映同位素异构体。为了支持反应的发展,并在上面确定的第二个挑战,分子旋转共振(MRR)光谱被建立作为一种通用的分析技术,以量化对映体过量的对映体同位素物质,并确定其绝对构型。预计这项研究的结果将扩大选择性氚化小分子作为了解代谢物和/或药物制剂在生物系统中如何处理的有用工具的使用范围。该奖项反映了NSF的法定使命,并被认为值得通过使用基金会的知识价值和更广泛的影响审查标准进行评估来支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Clark其他文献

Value Creation of Mobile Services Through Presence: Designing Mobile Information and Entertainment Applications with Presence in Mind
通过存在感创造移动服务的价值:设计移动信息和娱乐应用时考虑到存在感
Phase III AXIS trial for second-line metastatic renal cell carcinoma (mRCC): Effect of prior first-line treatment duration and axitinib dose titration on axitinib efficacy.
二线转移性肾细胞癌 (mRCC) 的 III 期 AXIS 试验:先前一线治疗持续时间和阿西替尼剂量滴定对阿西替尼疗效的影响。
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    45.3
  • 作者:
    B. Rini;B. Escudier;M. Michaelson;S. Négrier;M. Gore;S. Oudard;Joseph Clark;J. Tarazi;B. Rosbrook;S. Kim;R. Motzer
  • 通讯作者:
    R. Motzer
A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01)
  • DOI:
    10.1186/2051-1426-2-s3-p77
  • 发表时间:
    2014-01-01
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Joseph Clark;Lawrence Flaherty;Marc Ernstoff;Henry Koon;Mohammed Milhem;Gerald Militello;Sanjiv Agarwala;Brendan Curti;Lee Cranmer;Christopher D Lao;Theodore F Logan;Jose Lutzky;Venkatesh Rudrapatna;Gregory Daniels;Bret Taback;Sandra Aung;James Lowder;David Lawson
  • 通讯作者:
    David Lawson
Examining the Mechanisms of Religious Ecology on Population Health and Material Well-Being
考察宗教生态对人口健康和物质福祉的作用机制
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Joseph Clark
  • 通讯作者:
    Joseph Clark
MP96-06 TOPICAL RECTAL ANTISEPTIC AT TIME OF PROSTATE BIOPSY: HOW A RESIDENT PATIENT SAFETY PROJECT EVOLVED INTO INSTITUTIONAL PRACTICE
  • DOI:
    10.1016/j.juro.2017.02.3029
  • 发表时间:
    2017-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Rosa Park;Kalyan Dewan;Girish Kirimanjeswara;Joseph Clark;Matthew Kaag;Kathleen Lehman;Jay Raman
  • 通讯作者:
    Jay Raman

Joseph Clark的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目
基于Hydrodynamics-Reaction Kinetics耦合模型的厌氧膨胀床反应器三相流场数值模拟及生态-水力响应机制解析
  • 批准号:
    51078108
  • 批准年份:
    2010
  • 资助金额:
    36.0 万元
  • 项目类别:
    面上项目

相似海外基金

Accelerated Development of Pharmaceutical Processes Through Digitally Coupled Reaction Screening and Process Optimisation
通过数字耦合反应筛选和工艺优化加速制药工艺的开发
  • 批准号:
    EP/Z531339/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65万
  • 项目类别:
    Research Grant
Development of dynamic structure control technology for innovative reaction field
创新反应领域动态结构控制技术开发
  • 批准号:
    23K17848
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of carbon monoxide dehydrogenase model for the reverse water gas shift reaction at ambient conditions
环境条件下逆水煤气变换反应的一氧化碳脱氢酶模型的开发
  • 批准号:
    23KJ1738
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of fluorescence imaging technology of LAT1-expressing cancer cells using intracellular click reaction
利用细胞内点击反应开发表达 LAT1 的癌细胞荧光成像技术
  • 批准号:
    23KJ0588
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of artificial reaction intermediates by introduction of steric hindrance
通过引入空间位阻开发人工反应中间体
  • 批准号:
    23K18106
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of reaction-diffusion based neural network systems
基于反应扩散的神经网络系统的开发
  • 批准号:
    23H00506
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of MEMS-type gas sensors with ultra-high-sensitivity and super-selectivity by a double receptor as a reaction place.
以双受体为反应场所,开发超高灵敏度、超选择性的MEMS型气体传感器。
  • 批准号:
    23H01690
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Assessment Tools for Evaluating Organic Chemistry Learners' Understanding of Reaction Mechanisms
开发用于评估有机化学学习者对反应机理理解的评估工具
  • 批准号:
    2315626
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Standard Grant
Development of Remote Bismetalation Reaction of Alkenes via Chain Walking
链式行走烯烃远程双金属化反应的进展
  • 批准号:
    22KJ2699
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Travel: ISCRE 27: Chemical Reaction Engineering for Sustainable Development
旅行:ISCRE 27:促进可持续发展的化学反应工程
  • 批准号:
    2322459
  • 财政年份:
    2023
  • 资助金额:
    $ 65万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了